1.Risk Factors of Dementia.
Chan Nyoung LEE ; Kun Woo PARK
Journal of Korean Diabetes 2012;13(3):129-132
Dementia is a syndrome of global cognitive disability and is not a single disease. There are many risk factors of dementia, and some factors are adjustable. Therefore it is important to have knowledge about dementia risk factors, and modulate the risk factors for prevention of dementia. Through this paper, we review the risk factors for dementia with unadjustable factors (age, sex, genetic factors) and adjustable factors (diabetes melitus, hypertention, hypercholesterolemia, hypothyroidism, alcohol intake, depression, etc) in the aspects of the impact of them on the incidence of dementia.
Alzheimer Disease
;
Dementia
;
Dementia, Vascular
;
Depression
;
Hypercholesterolemia
;
Hypothyroidism
;
Incidence
;
Risk Factors
2.Regional Metabolic Changes Influencing Three-Dimensional Perception in Parkinson’s Disease
Yoonah PARK ; Kun-Woo PARK ; Chan-Nyoung LEE
Journal of Clinical Neurology 2022;18(4):447-452
Background:
and Purpose Stereopsis refers to the perception of depth and awareness of the distance of an object from the observer that results from the brain receiving visual stimuli from both eyes in combination. Patients with idiopathic Parkinson’s disease (PD patients) typically experience problems with vision, eyeball movements, and visual perception due to degeneration of the cells that generate dopamine in the brain. We therefore hypothesized that stereopsis is affected more by visual cortical dysfunction in idiopathic PD than by retina and subcortical structural dysfunction.
Methods:
We analyzed stereopsis in 12 PD patients and 7 healthy controls using a three-dimensional (3D) television (TV). Before allowing patients to watch TV, we examined their visual acuity and strabismus using the Titmus Stereo Fly Test, and evaluated their cognitive function using cognitive tests. The patients watched 3D and two-dimensional (2D) versions of a movie with an approximate duration of 17 minutes, and then completed a questionnaire about stereopsis. All subjects underwent brain F-18 fluorodeoxyglucose (FDG) positronemission tomography after watching the 3D version of the movie. One week later, subjects watched the 2D version of the same movie under the same conditions. Each scan was analyzed using statistical parametric mapping (version 8) software.
Results:
The visual cortex was activated less in the PD patients than in the healthy controls when watching the 2D or 3D movie. However, there was no significant difference between watching 2D and 3D movies in the PD patients or healthy controls.
Conclusions
The lower activation of the primary visual cortex in PD patients suggests the presence of dysfunction of the visual cortex. In addition, there was less activation of the visual association cortex in PD patients when watching a 3D movie than in controls under the same conditions. This might be one reason why PD patients do not recognize real and dynamic stereopsis. These findings have clinical significance since they suggest that safety needs to be considered when making devices or programs using 3D or virtual reality for use by patients with various cerebral degenerative diseases.
3.A Case of Transient Memory Impairment after Acute Left Focal Lateral Putamen ICH with Old Caudate Nucleus Infarction.
Chang Woon CHOI ; Chan Nyoung LEE ; Kun Woo PARK
Dementia and Neurocognitive Disorders 2012;11(4):154-157
Transient memory impairment can be occurred by many causes. One of them is acute focal brain lesion in strategic site. Caudate nucleus and medial basal ganglia (globus pallidus) are lesion of strategic site. They play its role in cognitive processing. But lateral basal ganglia (putamen) is known as a structure involving movement, not cognitive function. We report a interesting case of transient memory dysfunction with acute focal putamen ICH with old caudate nucleus infarction.
Basal Ganglia
;
Brain
;
Caudate Nucleus
;
Infarction
;
Intracranial Hemorrhages
;
Memory
;
Putamen
7.Chronic Inflammatory Demyelinating Polyneuropathy Developed during Interferon-beta Therapy in a Patient with Multiple Sclerosis.
Chan Nyoung LEE ; Byung Jo KIM ; Kun Woo PARK ; Seong Boem KOH ; Ho Jung KIM ; Dae Hie LEE
Journal of the Korean Neurological Association 2006;24(5):486-490
Preliminary studies have evaluated the effects of interferon beta formulations in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) because of pathogenic similarities between CIDP and multiple sclerosis (MS). However, the efficacy of Interferon, which has been widely used for relapsing-remitting MS, is controversial in CIDP. We report here a 31year old woman with relapsing-remitting type MS treated with IFN beta-1b over 2 years who developed overt CIDP. She responded favorably to steroids. This case suggests that IFN beta-1b treatment may not prevent development of CIDP.
Female
;
Humans
;
Interferon-beta*
;
Interferons
;
Multiple Sclerosis*
;
Polyneuropathies*
;
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
;
Steroids
8.Anti-N-Methyl-D-Aspartate Receptor Encephalitis Presenting Progressive Dyslexia: A Case Report.
Kwang Hyun PAN ; Jin Hee KIM ; Byung Jo KIM ; Chan Nyoung LEE
Dementia and Neurocognitive Disorders 2015;14(4):176-179
BACKGROUND: Anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis was discovered less than 10 years ago. Its symptoms and characteristics are not well-defined yet. We experienced a case of anti-NMDA receptor encephalitis with phonemic paraphasia and acalculia that were not classical characteristics. CASE REPORT: A 44-year-old woman started to show dyslexia, phonemic paraphasia, and dyscalculia. These symptoms were gradually worsening for over 30 days. Various brain images were not helpful for primary diagnosis. Anti-NMDA receptor encephalitis was confirmed in two different laboratories. The patient started to recover with various immunosuppressive therapies. CONCLUSIONS: Anti-NMDA receptor encephalitis can have various symptoms, including phonemic paraphasia and acalculia.
Adult
;
Anti-N-Methyl-D-Aspartate Receptor Encephalitis*
;
Brain
;
Diagnosis
;
Dyscalculia
;
Dyslexia*
;
Encephalitis
;
Female
;
Humans
9.A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease.
YoungSoon YANG ; Hojin CHOI ; Chan Nyoung LEE ; Yong Bum KIM ; Yong Tae KWAK
Dementia and Neurocognitive Disorders 2018;17(1):1-10
BACKGROUND AND PURPOSE: Acetyl-L-carnitine (ALC) is a widely used drug for various neurodegenerative diseases including dementia. The aim of the present study was to elucidate the efficacy of ALC in dementia patients with cerebrovascular disease (vascular cognitive impairment; VCI). METHODS: Fifty-six patients were randomized to treatment with 500 mg ter in die ALC, or placebo in this 28-week, double-blind, placebo-controlled trial. The primary outcome measure was the Korean version of Montreal Cognitive Assessment (MoCA-K). RESULTS: Following treatment with ALC, the cognitive function measured by the MoCA-K was significantly improved in the ALC-treated groups. However, other secondary outcomes were not statistically significant between ALC- and placebo-treated groups. In MoCA-K analysis, attention and language sub-items significantly favored the ALC-treated group. CONCLUSIONS: Compared with placebo, treatment with ALC 1,500 mg/day produced significant changes in MoCA-K in dementia patients with VCI. ALC was well tolerated in this population. Despite the study limitations, the findings suggested the potential benefits associated with the use of ALC in dementia patients with VCI.
Acetylcarnitine*
;
Cerebrovascular Disorders*
;
Cognition
;
Cognition Disorders
;
Dementia*
;
Humans
;
Neurodegenerative Diseases
;
Outcome Assessment (Health Care)
10.Survey of Current Status and Cognition of Activities of Daily Living in Dementia Patients: the 2018 “Il-sang-ye-chan” Campaign
Hojin CHOI ; Jeong Hoon BAE ; Jae Sung LIM ; Yeonsil MOON ; Kee Hyung PARK ; Seung Hyun KIM ; Chan Nyoung LEE
Dementia and Neurocognitive Disorders 2019;18(1):1-9
BACKGROUND AND PURPOSE: Disability associated with activities of daily living (ADL) is the basis of dementia diagnosis and is an important factor in the care of dementia patients. The status of awareness and burden of ADL disability in dementia patients was investigated six years ago and used as an important reference for “Il-sang-ye-chan” campaign. They were re-investigated in six years and compared with previous results. METHODS: The survey included caregivers of 100 dementia patients listed at the four regional dementia centers. Structured open and closed questions about ADL were asked. Assessments included age, sex, education level, economic status, severity of dementia, caregiving pattern, current statues and cognition of ADL, and caregiver needs. RESULTS: The cognition of ADL was still very low (43%). Increased stress among caregivers was the biggest burden, and they frequently suffered from outing disability (56%), recent memory loss (48%), and loss of bowel/bladder control (40%). The economic burden has been greatly reduced compared with the burden six years ago and the needs of caregivers were still highly about educational guide lines or programs. CONCLUSIONS: Continued interest and further investigation into ADL disability of dementia patients are needed. Korean Dementia Association will further expand the “Il-sang-ye-chan” program: via a multi-domain cognitive intervention program under the Care for ADL in dementia and Relieve symptoms in Dementia Project.
Activities of Daily Living
;
Caregivers
;
Cognition
;
Dementia
;
Diagnosis
;
Education
;
Humans
;
Memory Disorders